drugset / Trial / NCT02058940
Intravenous Exenatide in Patients With Acute Brain Injury
Phase 4
Completed
8 enrolled
University of North Carolina, Chapel Hill
AstraZeneca · collabMedtronic · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the feasibility of exenatide infusion for the treatment of high blood sugars following acute brain injury.
Timeline
- Start
- 2015-08
- Primary completion
- 2017-08
- Completion
- 2017-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 25 ng | Intravenous |